S&P 500
5,895.26
-0.3%
-$16.43
DJI
42,048.32
-0.5%
-$221.75
NASDAQ
19,095.26
-0.1%
-$18.50
Bitcoin
104,382.00
-0.3%
-303.11
AAPL
$200.97
+0.1%
+$0.12
AMZN
$204.32
-0.3%
-$0.69
GOOG
$170.03
-1.6%
-$2.82
META
$655.33
+1.2%
+$7.84
MSFT
$460.23
-0.0%
-$0.13
NVDA
$136.79
+1.2%
+$1.66
TSLA
$336.66
-2.8%
-$9.80
Plus Therapeutics (NASDAQ: PSTV)
$0.34
(18.4%)
$0.05
Price as of June 2, 2025, 10:42 a.m. ET
Plus Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Plus Therapeutics Company Info
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.